Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Gore

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
BMC Bioinformatics|March 12, 2024
DiseaseNet: a transfer learning approach to noncommunicable disease classificationSteven Gore, Bailey Meche, Danyang Shao, et al.
Developmental Biology|January 24, 2012
Multiple RNA-binding proteins function combinatorially to control the soma-restricted expression pattern of the E3 ligase subunit ZIF-1Marieke Oldenbroek, Scott M Robertson, Tugba Guven-Ozkan, et al.
Scientific Reports|July 2, 2025
RareNet: a deep learning model for rare cancer diagnosisDanyang Shao, Sohan Addagudi, Joseph Cowles, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2010
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapyMartin Tallman, Dan Douer, Steven Gore, et al.
Biomedical Chromatography : BMC|October 8, 2024
Quantitation of the DNA-dependent protein kinase inhibitor peposertib (M3814) and metabolite in human plasma by LC-MS/MSSusan M Christner, Robert A Parise, Christopher J Bakkenist, et al.
Genetics|May 31, 2019
Role of the Srs2-Rad51 Interaction Domain in Crossover Control in <i>Saccharomyces cerevisiae</i>Shirin S Jenkins, Steven Gore, Xiaoge Guo, et al.
Leukemia & Lymphoma|December 16, 2020
High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasisJennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, et al.
Leukemia Research|December 24, 2013
Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study modelPierre Fenaux, John F Seymour, Valeria Santini, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Rad51 determines pathway usage in post-replication repairDamon Meyer, Shannon J Ceballos, Steven Gore, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2015
Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based SurveyEun-Ju Lee, B Douglas Smith, Jessica W Merrey, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
BMC Bioinformatics|March 12, 2024
DiseaseNet: a transfer learning approach to noncommunicable disease classificationSteven Gore, Bailey Meche, Danyang Shao, et al.
Developmental Biology|January 24, 2012
Multiple RNA-binding proteins function combinatorially to control the soma-restricted expression pattern of the E3 ligase subunit ZIF-1Marieke Oldenbroek, Scott M Robertson, Tugba Guven-Ozkan, et al.
Scientific Reports|July 2, 2025
RareNet: a deep learning model for rare cancer diagnosisDanyang Shao, Sohan Addagudi, Joseph Cowles, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2010
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapyMartin Tallman, Dan Douer, Steven Gore, et al.
Biomedical Chromatography : BMC|October 8, 2024
Quantitation of the DNA-dependent protein kinase inhibitor peposertib (M3814) and metabolite in human plasma by LC-MS/MSSusan M Christner, Robert A Parise, Christopher J Bakkenist, et al.
Genetics|May 31, 2019
Role of the Srs2-Rad51 Interaction Domain in Crossover Control in <i>Saccharomyces cerevisiae</i>Shirin S Jenkins, Steven Gore, Xiaoge Guo, et al.
Leukemia & Lymphoma|December 16, 2020
High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasisJennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, et al.
Leukemia Research|December 24, 2013
Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study modelPierre Fenaux, John F Seymour, Valeria Santini, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Rad51 determines pathway usage in post-replication repairDamon Meyer, Shannon J Ceballos, Steven Gore, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2015
Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based SurveyEun-Ju Lee, B Douglas Smith, Jessica W Merrey, et al.
Pageof 4